Skip to main content

Stonepine Capital Management, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1440771 BEND, OR

Position in XERS

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$0
-$232,174 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
15 quarters on record

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Derivatives in XERS

reported options exposure · as of Jun 30, 2026
CallValue
$2,217,600
CallShares
280,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $17,591,704 across 4 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,217,600 280,000
2026-03-31 $1,624,000 280,000
2026-03-31 $232,174 40,030
2025-06-30 $957,817 205,100
2025-03-31 $561,434 102,265
2024-12-31 $618,054 182,317
2024-03-31 $1,321,770 598,086
2023-12-31 $13,951,950 5,937,000
2023-09-30 $11,002,591 5,915,372
2023-06-30 $14,410,597 5,500,228
2023-03-31 $14,083,534 8,640,205
2022-12-31 $14,889,601 11,195,189
2022-09-30 $20,167,942 12,928,168
2022-06-30 $17,937,022 11,647,417
2022-03-31 $20,285,583 7,924,056
2021-12-31 $16,573,172 5,656,373